US FDA Wants Opioid Prescribing Guidelines To Be Highly Specific, But It May Have To Compromise

National Academies of Sciences, Engineering, and Medicine committee meeting suggest it is difficult to write condition-specific guidelines for opioid prescribing in the primary care setting.

Arrows miss target

The US FDA is hoping that the National Academies of Sciences, Engineering, and Medicine (NASEM) can help develop opioid prescribing guidelines that are highly specific, although experts cautioned there are some areas where guidelines may need to be more generalizable.

Speaking at a Feb. 4 meeting hosted by NASEM's Committee on Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet